A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection

NCT02292706 · clinicaltrials.gov ↗

TERMINATED

Status

1609

Enrollment

INDUSTRY

Sponsor class

Stopped The study stopped early because the study objectives were met.

Conditions

Hepatitis C Virus Infection

Interventions

DRUG: Sofosbuvir
DRUG: Ribavirin
DRUG: LDV/SOF
DRUG: SOF/VEL
DRUG: SOF/VEL/VOX
DRUG: Other SOF-Based Regimen
OTHER: Ineligible parent treatment

Sponsor

Gilead Sciences